Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study

This publication has 18 references indexed in Scilit:

• Commonality of the IL-4/IL-13 pathway in atopic diseases
  Expert Review of Clinical Immunology, 2017
• Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
  The Lancet, 2016
• Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis
  The Lancet Respiratory Medicine, 2016
• Type 2 inflammation in asthma — present in most, absent in many
  Nature Reviews Immunology, 2014
• Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice
  Proceedings of the National Academy of Sciences, 2014
• Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes
  Proceedings of the National Academy of Sciences, 2014
• Exploring the Effects of Omalizumab in Allergic Asthma
  American Journal of Respiratory and Critical Care Medicine, 2013
• The natural history of asthma
  Journal of Allergy and Clinical Immunology, 2006
• The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma
  Clinical & Experimental Allergy, 2005
• Slowing the Deterioration of Asthma and Chronic Obstructive Pulmonary Disease Observed during Bronchodilator Therapy by Adding Inhaled Corticosteroids: A 4-Year Prospective Study
  Annals of Internal Medicine, 1993